证券记录 · 已归档季度
CLDX
Celldex Therapeutics, Inc. · Healthcare · Biotechnology
14被追踪持有人
0Δ持有人
33.46M持有股份
$680.97M报告持仓市值
+0新建仓位
−0清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 -7.5% · 净新建仓位 0.0% — 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 87 | +8 | 50.70M | $1.89B | +11 | −3 |
| Q1 2026 | 82 | +10 | 42.54M | $1.35B | +12 | −2 |
| Q4 2025 | 72 | 0 | 42.78M | $1.16B | — | — |
| Q3 2025 | 17 | 0 | 35.45M | $917.00M | — | — |
| Q2 2025 | 14 | 0 | 33.46M | $680.97M | — | — |
| Q1 2025 | 11 | -1 | 21.24M | $385.48M | — | −1 |
| Q4 2024 | 12 | +1 | 21.78M | $550.46M | +2 | −1 |
| Q3 2024 | 10 | -1 | 17.69M | $601.30M | — | −1 |
| Q2 2024 | 11 | — | 17.48M | $646.94M | — | — |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 5.55M | — | $112.94M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (被动) | 5.55M | — | $112.94M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (被动) | 5.55M | — | $112.94M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (被动) | 5.55M | — | $112.94M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 5.55M | — | $112.94M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 5.55M | — | $112.94M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 5.55M | — | $112.94M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 5.55M | — | $112.94M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 5.55M | — | $112.94M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (被动) | 5.55M | — | $112.94M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (被动) | 5.55M | — | $112.94M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (被动) | 5.55M | — | $112.94M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (被动) | 5.55M | — | $112.94M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (被动) | 5.55M | — | $112.94M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (被动) | 5.55M | — | $112.94M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Fidelity (FMR) ✦ | 5.44M | — | $110.69M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Fidelity (FMR) ✦ | 5.44M | — | $110.69M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Fidelity (FMR) ✦ | 5.44M | — | $110.69M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Fidelity (FMR) ✦ | 5.44M | — | $110.69M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Wellington Management ✦ | 5.23M | -37.4% | $106.48M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 21 | Wellington Management ✦ | 5.23M | -37.4% | $106.48M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 22 | Wellington Management ✦ | 5.23M | -37.4% | $106.48M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 23 | Wellington Management ✦ | 5.23M | -37.4% | $106.48M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 24 | Wellington Management ✦ | 5.23M | -37.4% | $106.48M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 25 | Wellington Management ✦ | 5.23M | -37.4% | $106.48M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 26 | Wellington Management ✦ | 5.23M | -37.4% | $106.48M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 27 | The Vanguard Group ✦ (被动) | 3.96M | — | $80.53M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | The Vanguard Group ✦ (被动) | 3.96M | — | $80.53M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | The Vanguard Group ✦ (被动) | 3.96M | — | $80.53M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | The Vanguard Group ✦ (被动) | 3.96M | — | $80.53M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | The Vanguard Group ✦ (被动) | 3.96M | — | $80.53M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | T. Rowe Price ✦ | 3.82M | +11.9% | $77.69M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 33 | T. Rowe Price ✦ | 3.82M | +11.9% | $77.69M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 34 | Point72 Asset Management ✦ | 2.80M | +6.9% | $57.02M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 35 | State Street Global Advisors ✦ (被动) | 2.41M | -14.3% | $48.95M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 36 | Geode Capital Management ✦ (被动) | 1.67M | +5.2% | $34.05M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 37 | Geode Capital Management ✦ (被动) | 1.67M | +5.2% | $34.05M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 38 | Fisher Asset Management ✦ | 822.21K | -5.7% | $16.73M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 39 | D. E. Shaw & Co. ✦ | 645.66K | +59.0% | $13.14M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 40 | D. E. Shaw & Co. ✦ | 645.66K | +59.0% | $13.14M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 41 | Millennium Management ✦ | 477.23K | +19.3% | $9.71M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 42 | Citadel Advisors ✦ | 378.74K | -37.2% | $7.71M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 43 | Citadel Advisors ✦ | 378.74K | -37.2% | $7.71M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 44 | Renaissance Technologies ✦ | 181.39K | +23.7% | $3.69M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 45 | Two Sigma Investments ✦ | 80.73K | +181.7% | $1.64M | 0.0% | ▲ Add | 3 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 227 持有人, 72.32M 股份, $2.21B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据